CAS NO: | 292632-98-5 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | L-685458 is a potent transition state analog (TSA)γ-secretaseinhibitor (GSI). L-685458 inhibits amyloid β-protein precursorγ-secretaseactivity withIC50of 17 nM, shows greater than 50-100-fold selectivity over other aspartyl proteases tested. L685458 inhibits γ-secretase-mediated cleavage of APP-C99 and Notch-100 with IC50s of 301.3 nM and 351.3 nM, respectively. L-685458 can be used for the research of alzheimer’s disease (AD) and cancers[1][2]. | ||||||||||||||||
体外研究 (In Vitro) | L-685458 reduces both Aβ(40) and Aβ(42) peptide formation in 3 different cells. It against Neuro2A h AβPP695, CHO h AβPP695, and SHSY5 spβA4CTF reduction of Aβ(40) with IC50values of 402 nM, 113 nM and 48 nM, respectively. And the IC50values are 775 nM, 248 nM, 67 nM, respectively[1].L-685458 (5-40 μM; 24 hours) leads to a dramatic downregulation of Hes-1 in 786-O cells[3].L-685458 has inhibitory effects in hepatoma cell lines, it against Huh7, HepG2, HLE and SKHep1 cells with IC50of 12.91 μM, 12.69 μM, 21.76 μM and 12.18 μM, respectively[4]. | ||||||||||||||||
体内研究 (In Vivo) | L-685458 (percutaneous administration; 5 mg/kg; 2 weeks) has antitumor effects in mouse hepatoma models. L-685458 inhibits EpCAM production except in necrotic areas. And HES1 staining is also diminished in the nucleus[4].
| ||||||||||||||||
分子量 | 672.85 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C39H52N4O6 | ||||||||||||||||
CAS 号 | 292632-98-5 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 83.3 mg/mL(123.80 mM;Need ultrasonic and warming) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |